Use of Arterio-venous Fistula as First Choice for Intravenous Drug Administration in Kidney Transplant Recipients

University Hospital, Angers50 enrolled

Overview

Use of arteriovenous fistula for IV drug administration is controversial and often prohibited by nephrologists. However, we have been using this method in our department for years now in order to keep the patients 'veins for other fistulas in the future. The aim of this study is to evaluate our practice and maybe provide a justification for a larger multi-center study given the importance of this subject in patients with chronic renal failure.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Evaluate the Risks of Using Arteriovenous Fistula as First Choise for Drug Administration

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age \> 18 years, functional AV fistula, new kidney transplant recipient Exclusion Criteria: * Prothetic AV fistula, Very recent AV fistula of less than 3 months

Locations (1)

CHU Angers

Angers, France

RECRUITING

Outcomes

Primary Outcomes

Evaluate the risk of complications of AV fistula

Time frame: 12 months

Central Contacts

Christelle Roux

CONTACT

Christelle.Roux@chu-angers.fr

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.